Bergren M S, Battle M M, Halstead G W, Theis D L
Control Research Laboratories, Upjohn Company, Kalamazoo, MI 49001.
J Pharm Biomed Anal. 1989;7(5):549-61. doi: 10.1016/0731-7085(89)80220-1.
The effect of temperature on drug release from meteneprost potassium vaginal suppositories was investigated using a dissolution test based on the USP I apparatus. Comparison of the dissolution results with the DSC melting behaviour revealed that drug release was extremely slow until melting of the suppository was essentially complete. The melting behaviour of the meteneprost potassium suppositories was also varied by preparing suppositories from bases with higher and broader melting ranges. The observed dissolution behaviour (at 37 degrees C) confirmed that drug release increased as the melting temperature of a particular suppository decreased. Differential scanning calorimetry, viscosity and dilatometry methods were used to characterize the suppository melting process. The effects of suppository melting range, melt temperature and composition were investigated with respect to in vitro drug release. Methodology for the HPLC determination of meteneprost in suppositories and in dissolution media are also reported.
采用基于美国药典I装置的溶出度试验,研究了温度对美替前列醇钾阴道栓药物释放的影响。将溶出结果与差示扫描量热法(DSC)的熔融行为进行比较,结果表明,在栓剂基本完全熔化之前,药物释放极其缓慢。通过使用熔点范围更高、更宽的基质制备栓剂,美替前列醇钾栓剂的熔融行为也有所不同。观察到的溶出行为(在37℃)证实,随着特定栓剂熔融温度的降低,药物释放增加。采用差示扫描量热法、粘度法和膨胀法对栓剂的熔融过程进行了表征。研究了栓剂熔融范围、熔融温度和组成对体外药物释放的影响。还报道了用高效液相色谱法测定栓剂和溶出介质中美替前列醇的方法。